<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drug\PMC6958466\results\search\disease\results.xml">
  <result pre="work together to proactively combat ZIKV or future emerging pathogens." exact="viral" post="epidemics Zika virus (ZIKV) SIR models 2D graphical method"/>
  <result pre="the corpsesâ€™ eyes, eating them away.â€�A Medieval Song about the" exact="Plague" post="(http://www.historyofpainters.com/plague_art.htm) â€œHow many valiant men, how many fair ladies,"/>
  <result pre="and Asia at first. The first major outbreak of ZIKV" exact="infection" post="was reported from the Yap Island in the Federated"/>
  <result pre="was a report of the first three cases of ZIKV" exact="infection" post="in humans in Oyo state, Nigeria [2]. In 1979,"/>
  <result pre="[4,5]. After 11 years of this observation, the first human" exact="infections" post="in Asia were discovered in central Java of Indonesia"/>
  <result pre="eastward transmission to south-eastern Asia, Oceania, South America, Caribbean, and" exact="Central" post="America.â€� Concerning this Africa to Asia spread, these authors"/>
  <result pre="World War in south-eastern Asia, around 100,000 East and West" exact="African" post="soldiers were brought into combat in the Burma Campaign"/>
  <result pre="(East Africa) Infantry Division comprised troops from East and West" exact="African" post="countries such as Kenya, Uganda, Nyasaland, Tanganyika, and Rhodesia"/>
  <result pre="Uganda, Nyasaland, Tanganyika, and Rhodesia (Burma Star Associationâ€&quot;The 11th East" exact="African" post="Division). During those three yearsâ€™ conflict, both sides suffered"/>
  <result pre="including at least 20,000 Japanese soldiers who died because of" exact="disease" post="in the battle of Imphal. It is also noteworthy"/>
  <result pre="virus attracted a heightened international attention following huge incidence of" exact="microcephaly" post="in neo-natal cases in the Latin Americas in 2015"/>
  <result pre="2016, WHO [1] declared that the recent association of Zika" exact="infection" post="with clusters of microcephaly and other neurological disorders constituted"/>
  <result pre="that the recent association of Zika infection with clusters of" exact="microcephaly" post="and other neurological disorders constituted a Public Health Emergency"/>
  <result pre="Flaviviridae family. Some important disease-causing viruses of this genus are" exact="Dengue" post="fever virus, Tick-borne encephalitis virus, West Nile virus, Japanese"/>
  <result pre="disease-causing viruses of this genus are Dengue fever virus, Tick-borne" exact="encephalitis" post="virus, West Nile virus, Japanese encephalitis virus, and Zika"/>
  <result pre="are Dengue fever virus, Tick-borne encephalitis virus, West Nile virus," exact="Japanese encephalitis" post="virus, and Zika virus [10]. These viruses possess a"/>
  <result pre="Dengue fever virus, Tick-borne encephalitis virus, West Nile virus, Japanese" exact="encephalitis" post="virus, and Zika virus [10]. These viruses possess a"/>
  <result pre="translated into a large polyprotein that is subsequently converted by" exact="viral" post="and host cell proteases into two sets of proteins:"/>
  <result pre="[15,16]. After endocytosis mediated by a still unknown cellular receptor," exact="viral" post="fusion occurs with endosomal membranes. This results in the"/>
  <result pre="with endosomal membranes. This results in the uncoating of the" exact="viral" post="particle and release of the viral genome. The genome"/>
  <result pre="the uncoating of the viral particle and release of the" exact="viral" post="genome. The genome is subsequently translated into a single"/>
  <result pre="at the endoplasmic reticulum (ER). The polyprotein is processed by" exact="viral" post="NS2Bâ€&quot;NS3 protease and other cellular proteases generating mature viral"/>
  <result pre="by viral NS2Bâ€&quot;NS3 protease and other cellular proteases generating mature" exact="viral" post="proteins. The positive-sense viral RNA genome is then copied"/>
  <result pre="and other cellular proteases generating mature viral proteins. The positive-sense" exact="viral" post="RNA genome is then copied to produce a negative-sense"/>
  <result pre="the template for the synthesis of the full length positive-sense" exact="viral" post="genomic RNA. Synthesis of viral genome occurs in association"/>
  <result pre="of the full length positive-sense viral genomic RNA. Synthesis of" exact="viral" post="genome occurs in association with the ER and is"/>
  <result pre="are two major groups: one with older sequences from the" exact="African" post="continent and another with more recent Asian, Pacific, and"/>
  <result pre="African continent and another with more recent Asian, Pacific, and" exact="American" post="sequences. The structural differences among these two groups are"/>
  <result pre="to the present time, is given in Table 3. 3." exact="Infection" post="3.1. Clinical Symptoms and Complications The Centers for Disease"/>
  <result pre="3. Infection 3.1. Clinical Symptoms and Complications The Centers for" exact="Disease" post="Control and Prevention [20] gives a detailed list of"/>
  <result pre="list of information about the clinical aspects of the Zika" exact="virus infection." post="A majority of people infected with Zika virus do"/>
  <result pre="not develop too many overt symptoms. Typical symptoms of Zika" exact="virus infection" post="include mild fever, rash, joint/muscle pain, headache, and conjunctivitis."/>
  <result pre="develop too many overt symptoms. Typical symptoms of Zika virus" exact="infection" post="include mild fever, rash, joint/muscle pain, headache, and conjunctivitis."/>
  <result pre="people recover from these symptoms in around a week. ZIKV" exact="infection" post="during pregnancy has been linked to several complications, which"/>
  <result pre="linked to several complications, which are collectively referred to as" exact="congenital" post="Zika syndrome. These include miscarriage, severe microcephaly, and other"/>
  <result pre="Zika syndrome. These include miscarriage, severe microcephaly, and other fetal" exact="brain" post="defects, lasting tissue damage in brain, eye damage [20,21]."/>
  <result pre="and other fetal brain defects, lasting tissue damage in brain," exact="eye damage" post="[20,21]. Another complication of ZIKV infection is its association"/>
  <result pre="damage in brain, eye damage [20,21]. Another complication of ZIKV" exact="infection" post="is its association with the Guillainâ€&quot;BarrÃ© syndrome (GBS), a"/>
  <result pre="complication of ZIKV infection is its association with the Guillainâ€&quot;BarrÃ©" exact="syndrome" post="(GBS), a neurological disorder [22,23]. 3.2. Modes of Transmission"/>
  <result pre="infection is its association with the Guillainâ€&quot;BarrÃ© syndrome (GBS), a" exact="neurological disorder" post="[22,23]. 3.2. Modes of Transmission The current CDC website"/>
  <result pre="symptoms, and after their symptoms end. This scenario of ZIKV" exact="disease" post="transmission is not without precedents in the human history."/>
  <result pre="precedents in the human history. The first incidences of possibly" exact="smallpox" post="in Europe was the Antonine Plague of 165 to"/>
  <result pre="first incidences of possibly smallpox in Europe was the Antonine" exact="Plague" post="of 165 to 180 AD, also known as the"/>
  <result pre="Plague of 165 to 180 AD, also known as the" exact="Plague" post="of Galen (from the name of the Greek physician"/>
  <result pre="by troops returning from the Near East campaigns [25]. The" exact="Plague" post="of Justinian (541â€&quot;542 AD) afflicted the Eastern Roman (Byzantine)"/>
  <result pre="came through rodents in ships carrying grain to Rome. Smallpox" exact="infections" post="that decimated the native populations of the New World"/>
  <result pre="was carried there by the Spanish conquistadores [26]; in turn" exact="syphilis" post="was carried eastward from the New World to Europe"/>
  <result pre="d t = Î³ I . Here Î² is the" exact="disease" post="transmission rate from an infectious person to a susceptible"/>
  <result pre=". Here Î² is the disease transmission rate from an" exact="infectious" post="person to a susceptible person, and Î³ is the"/>
  <result pre="models and their extensions. Its relevance in modelling of several" exact="disease" post="spreads, accounting for context-specific priorities like mortality, population growth,"/>
  <result pre="of the spread of ZIKA are based on estimating its" exact="infectious" post="effect. This is obtained through a quantity called basic"/>
  <result pre="by R0. This is defined as the average number of" exact="infections" post="caused by an infected person among the population which"/>
  <result pre="v ( t ) are the time-varying rates of mosquito-to-human" exact="infection" post="and mosquito birth, respectively, and other parameters are the"/>
  <result pre="model accounting for variable biting rate can accurately predict future" exact="disease" post="incidences. Data-driven modelling strategies for countering Zika have been"/>
  <result pre="now, effective vaccines are available for only a handful of" exact="infectious diseases." post="In this section, we will look at the current"/>
  <result pre="that remain in the host bloodstream. In a subsequent naturally" exact="acquired" post="infection by the same pathogen, the memory cells will"/>
  <result pre="remain in the host bloodstream. In a subsequent naturally acquired" exact="infection" post="by the same pathogen, the memory cells will be"/>
  <result pre="organisms. In the Flaviviridae family, vaccines are available for the" exact="yellow fever" post="virus (YFV) and Japanese encephalitis virus (JEV). There are"/>
  <result pre="vaccines are available for the yellow fever virus (YFV) and" exact="Japanese encephalitis" post="virus (JEV). There are two types of JEV vaccine"/>
  <result pre="are available for the yellow fever virus (YFV) and Japanese" exact="encephalitis" post="virus (JEV). There are two types of JEV vaccine"/>
  <result pre="weakened YFV strain [47]. None exist for the Zika or" exact="Dengue" post="viruses. An important point to note is that vaccines,"/>
  <result pre="whole Zika virus (ZIKV) vaccines. Additionally, there are two recombinant" exact="viral" post="vectors, a peptide vaccine based on mosquito salivary proteins"/>
  <result pre="antibody dependent enhancement or ADE. Reportedly, in cases of a" exact="secondary" post="Dengue infection, it has been seen that the disease"/>
  <result pre="dependent enhancement or ADE. Reportedly, in cases of a secondary" exact="Dengue" post="infection, it has been seen that the disease severity"/>
  <result pre="a secondary Dengue infection, it has been seen that the" exact="disease" post="severity is amplified and a probable cause is an"/>
  <result pre="probable cause is an abnormal behavior of the antibodies against" exact="Dengue" post="virusâ€&quot;they aid in the virulence of this arbovirus resulting"/>
  <result pre="virusâ€&quot;they aid in the virulence of this arbovirus resulting in" exact="Dengue" post="Shock Syndrome or Dengue Hemorrhagic Fever [49]. Since Zika"/>
  <result pre="aid in the virulence of this arbovirus resulting in Dengue" exact="Shock" post="Syndrome or Dengue Hemorrhagic Fever [49]. Since Zika is"/>
  <result pre="in the virulence of this arbovirus resulting in Dengue Shock" exact="Syndrome" post="or Dengue Hemorrhagic Fever [49]. Since Zika is closely"/>
  <result pre="virulence of this arbovirus resulting in Dengue Shock Syndrome or" exact="Dengue" post="Hemorrhagic Fever [49]. Since Zika is closely related to"/>
  <result pre="of this arbovirus resulting in Dengue Shock Syndrome or Dengue" exact="Hemorrhagic" post="Fever [49]. Since Zika is closely related to Dengue,"/>
  <result pre="this arbovirus resulting in Dengue Shock Syndrome or Dengue Hemorrhagic" exact="Fever" post="[49]. Since Zika is closely related to Dengue, an"/>
  <result pre="leading to unforeseen genetic response; these are some of the" exact="primary" post="challenges that are met in the vaccine production industry."/>
  <result pre="vaccine production industry. A major setback posed is by the" exact="short" post="efficacy of one of the largest productions of antiviral"/>
  <result pre="Such epitopes are then tested for population HLA sensitivity and" exact="autoimmune" post="risks. Finally, rank-based epitopes are chosen for further experimental"/>
  <result pre="NS5-based peptide vaccines that targets both Zika as well as" exact="Dengue" post="viruses. Furthermore, Richner et al. (2017) [58] assembled modified"/>
  <result pre="degree of variability in a region. The higher the conservation," exact="lower" post="the amino acid variability. It must be noted that"/>
  <result pre="similarity will eliminate any peptide candidate likely to cause an" exact="autoimmune" post="response. With this exercise, the conserved peptides with high"/>
  <result pre="exercise, the conserved peptides with high solvent accessibility and no" exact="autoimmune" post="threats are to be tested for in vitro and"/>
  <result pre="Watson is reported to be already more efficient in detecting" exact="cancer" post="symptoms than humans; precision vaccine design by AI may"/>
  <result pre="sudden eruption in South America in 2015â€&quot;16 except for sporadic" exact="infections" post="around the globe such as in Ahmedabad, India in"/>
  <result pre="can lead to severe physiological disorders such as compound organ" exact="infections" post="and organ failures, believed to arise from the severe"/>
  <result pre="another 4.55% change from Asia to the Americas. When a" exact="viral" post="pathogen suddenly emerges, it is important that we compare"/>
  <result pre="powerful beyond imagination.â€�Albert Einstein ZIKV is a flavivirus family of" exact="infection" post="transmitted by mosquitos. Because of a series of recent"/>
  <result pre="it became a serious pandemic situation. The concern for the" exact="infection" post="heightened because of babies born from ZIKV infected mothers"/>
  <result pre="heightened because of babies born from ZIKV infected mothers showed" exact="microcephaly" post="and neurological complications [84]. Since neither any drug nor"/>
  <result pre="necessary in order to discover a drug molecule for a" exact="disease" post="[89]. For accurate estimate of stereoelectronic properties, quantum chemical"/>
  <result pre="discovery of ZIKV drugs and are thus further discussed below." exact="Viral" post="proteins as ZIKV drug targets: Viral glycoproteins play important"/>
  <result pre="thus further discussed below. Viral proteins as ZIKV drug targets:" exact="Viral" post="glycoproteins play important roles for virus infection and replication"/>
  <result pre="as ZIKV drug targets: Viral glycoproteins play important roles for" exact="virus infection" post="and replication processes as it is involved with virus"/>
  <result pre="ZIKV drug targets: Viral glycoproteins play important roles for virus" exact="infection" post="and replication processes as it is involved with virus"/>
  <result pre="general, small molecules interfering with the function of any ZIKV" exact="viral" post="proteins should have the potential to restrict virus replication"/>
  <result pre="are well documented for anti-ZIKV activity [114]. Several inhibitors targeting" exact="viral" post="proteins that have been identified from high-throughput cell-based screening,"/>
  <result pre="experimental evaluation. Four out of these ten compounds exhibited experimental" exact="viral" post="growth inhibition below 20 mM concentration with one inhibitor"/>
  <result pre="to carry out the core functions that are essential to" exact="viral" post="replication. Therefore, inhibition of the viral protein functions could"/>
  <result pre="that are essential to viral replication. Therefore, inhibition of the" exact="viral" post="protein functions could be an attractive target for ZIKV"/>
  <result pre="analogs have been commonly used as antiviral agents for human" exact="viral" post="infections for many years [124]. Nucleosides from the host"/>
  <result pre="have been commonly used as antiviral agents for human viral" exact="infections" post="for many years [124]. Nucleosides from the host cell"/>
  <result pre="index values and found to be a selective inhibitor of" exact="viral" post="RNA-dependent RNA polymerase (RdRp). The compound has also shown"/>
  <result pre="50% of the infected mice from death without symptoms of" exact="neurological disorder" post="[129], the compound was discarded to other undesirable toxic"/>
  <result pre="ZIKV RdRp, acting as an allosteric agent to block the" exact="viral" post="RNA synthesis. Furthermore, in vivo studies (25 mg/kg) in"/>
  <result pre="with the compound, TPB showed a reduction of 40-fold plasma" exact="viral" post="load compared to the untreated controls. In addition, PK"/>
  <result pre="Thus, TPB appears to be a promising compound against ZIKV" exact="infection" post="[130]. Another non-nucleoside inhibitor, emetine was reported to potently"/>
  <result pre="serum and liver, respectively [131]. Host cell lipid biosynthesis inhibitors:" exact="Viral" post="infections including dengue and ZIKV are known to be"/>
  <result pre="and liver, respectively [131]. Host cell lipid biosynthesis inhibitors: Viral" exact="infections" post="including dengue and ZIKV are known to be associated"/>
  <result pre="and disruptions in the membrane structure of infected cells [133]." exact="Cholesterol" post="is found to modulate the host response of several"/>
  <result pre="screen by measuring the caspase-3 activity and cell viability with" exact="primary" post="hits, Xu et al. were able to discover PHA-690509,"/>
  <result pre="PHA-690509, a cyclin- dependent kinase inhibitor (CDKi), that inhibited ZIKV" exact="infection" post="with an EC50 value of 1.72 mM [94]. Additional"/>
  <result pre="known as roscovitine) and RGB-286147 were found to inhibit ZIKV" exact="infection" post="at sub micro molar concentrations [95]. From these results,"/>
  <result pre="to identify potential antiâ€&quot;ZIKV compounds. The CDK pharmacophore model on" exact="malaria" post="allowed identification of several new antimalarial CDK inhibitors [136]."/>
  <result pre="to be a target for discovery of compounds against ZIKV" exact="infection" post="[137]. The inhibitors for the receptor seem to function"/>
  <result pre="in silico methods [106]. Although Axl is thought to mediate" exact="viral" post="attachment to the host cells, the absolute mechanism of"/>
  <result pre="the absolute mechanism of function is not fully understood [138]." exact="Protein" post="metabolism disruptors: Viral replication depends upon the protein metabolism"/>
  <result pre="of function is not fully understood [138]. Protein metabolism disruptors:" exact="Viral" post="replication depends upon the protein metabolism or ER functions,"/>
  <result pre="which are intimately associated with the intracellular membrane where the" exact="viral" post="polyprotein is expressed and processed [139]. However, these processes"/>
  <result pre="PRVABC59 strains (EC50 &amp;gt; 50 mM in both cases) [112]." exact="Viral" post="entry blockers: Viral entry blockers, such as saliphenylhalamide (SaliPhe),"/>
  <result pre="&amp;gt; 50 mM in both cases) [112]. Viral entry blockers:" exact="Viral" post="entry blockers, such as saliphenylhalamide (SaliPhe), act by the"/>
  <result pre="value of 0.37 mM based on the measurement of intracellular" exact="viral" post="RNA [95]. Incidentally, niclosamide is an FDA-approved drug, mainly"/>
  <result pre="an FDA-approved drug, mainly used in the treatment of intestinal" exact="helminthiasis" post="and also in pregnancy. However, the drug has not"/>
  <result pre="[144], long noncoding RNAs [145], interfering peptides [146,147], compounds targeting" exact="viral" post="RNA [148,149,150], and computer-assisted molecular design including pharmacophore modeling"/>
  <result pre="two targets UV-4 and UV-5 have shown to reduce filovirus" exact="infections" post="in vitro and in vivo, including DENV infection [160]."/>
  <result pre="reduce filovirus infections in vitro and in vivo, including DENV" exact="infection" post="[160]. Therefore, these novel host-based targets have the potential"/>
  <result pre="agents are increasingly becoming important for the treatment of cancers," exact="infectious diseases," post="and autoimmune disorders, the approach may also be worthwhile"/>
  <result pre="becoming important for the treatment of cancers, infectious diseases, and" exact="autoimmune" post="disorders, the approach may also be worthwhile for developing"/>
  <result pre="experimental assay from a large pool of compounds in a" exact="short" post="time. This approach thus cannot only provide useful insights"/>
  <result pre="assessment, and the prevention as well as mitigation of the" exact="infectious" post="epidemic/pandemic: (a)External characterization: modelling of disease spread mechanisms, vectors,"/>
  <result pre="as mitigation of the infectious epidemic/pandemic: (a)External characterization: modelling of" exact="disease" post="spread mechanisms, vectors, and reservoirs of ZIKV (and emerging"/>
  <result pre="future pathogens using computational methods. 5.1. Quantitative Characterization of ZIKV" exact="Infection" post="In the realm of mathematical epidemiology discussed in Section"/>
  <result pre="gives us the ability to predict the trajectory of an" exact="infection" post="process in a compact manner [167]. In recent years,"/>
  <result pre="SIR model have been explored for the prediction of ZIKV" exact="infection" post="[30,31,32,33,34,35,36]. Besides SIR-type models, public health management in the"/>
  <result pre="alone or a collection of them, can be used for" exact="viral" post="sequence comparison. These methods are known as â€œalignment-freeâ€� techniques,"/>
  <result pre="PC2 plot in Figure 4 which can clearly separate the" exact="African" post="ZIKV sequences from those from Asia and South America."/>
  <result pre="will be able to place a novel or newly emerging" exact="viral" post="sequence close to a similar set of objects and"/>
  <result pre="fairly well reflects the changes in base distributions in the" exact="viral" post="sequences and can be adapted for monitoring sequence shifts"/>
  <result pre="and costly affair, poorly suited to the current circumstances where" exact="viral" post="epidemics are more frequent and affects large swathes of"/>
  <result pre="and affects large swathes of the human population within a" exact="short" post="time. Peptide vaccines developed ab initio against newly emerging"/>
  <result pre="traditional vaccines like live attenuated or inactivated vaccines come up" exact="short" post="on. While peptide vaccines have been in use in"/>
  <result pre="of the local populations promise more effective vaccination against emerging" exact="viral" post="epidemics and pandemics. While quantitative and computational initiatives has"/>
  <result pre="prioritization of chemicals has the potential to judiciously use the" exact="limited" post="resources available to the vaccine/drug designer. To this end,"/>
  <result pre="specifically on 17th July 2019, the WHO declared the Ebolavirus" exact="disease" post="(EVD, or Ebola) outbreak in the Democratic Republic of"/>
  <result pre="â&quot;� 53 will lie nearly on a subspace of dimension" exact="lower" post="than 53. The method of principal component analysis (PCA)"/>
  <result pre="2019) 2.MacNamaraF.N.Zika virus: A report on three cases of human" exact="infection" post="during an epidemic of jaundice in NigeriaTrans. R. Soc."/>
  <result pre="of jaundice in NigeriaTrans. R. Soc. Trop. Med. Hyg.19544813914510.1016/0035-9203(54)90006-113157159 3.FagbamiA.H.Zika" exact="virus infection" post="in Nigeria: Virology and seroepidemological investigation in Oyo stateJ."/>
  <result pre="jaundice in NigeriaTrans. R. Soc. Trop. Med. Hyg.19544813914510.1016/0035-9203(54)90006-113157159 3.FagbamiA.H.Zika virus" exact="infection" post="in Nigeria: Virology and seroepidemological investigation in Oyo stateJ."/>
  <result pre="Trop. Med. Hyg.19691841141510.4269/ajtmh.1969.18.4114976739 6.OlsonJ.G.KsiazekT.G.TriwibowoS.Zika virus, a cause of fever in" exact="Central" post="Java, IndonesiaTrans. R. Soc. Trop. Med. Hyg.19817538939310.1016/0035-9203(81)90100-06275577 7.LiangD.LeungR.K.K.LeeS.S.KamK.M.Insights into"/>
  <result pre="spread of Zika virusPLoS ONE201712e017671010.1371/journal.pone.017671028448611 8.WHO Report on Zika VIRUS," exact="Microcephaly" post="and Guillainâ€&quot;BarrÃ© SyndromeAvailable online: http://apps.who.int/iris/bitstream/handle/10665/204609/zikasitrep_10Mar2016_eng.pdf;jsessionid=F9E4895E6176562081D34C0DED1A6550?sequence=1(accessed on 7 July 2019)"/>
  <result pre="and Guillainâ€&quot;BarrÃ© SyndromeAvailable online: http://apps.who.int/iris/bitstream/handle/10665/204609/zikasitrep_10Mar2016_eng.pdf;jsessionid=F9E4895E6176562081D34C0DED1A6550?sequence=1(accessed on 7 July 2019) 9.NandyA.BasakS.C.The" exact="Epidemic" post="that Shook the Worldâ€&quot;The Zika Virus RampageExplor. Res. Hypothesis"/>
  <result pre="flavivirus 3â€² untranslated regionVirus Res.2015206536110.1016/j.virusres.2015.01.02625660582 15.BarzonL.TrevisanM.SinigagliaA.LavezzoE.PaluG.Zika virus: From pathogenesis to" exact="disease" post="controlFEMS Microbiol. Lett.2016363fnw20210.1093/femsle/fnw20227549304 16.SutharM.S.DiamondM.S.GaleM.Jr.West Nile virus infection and immunityNat."/>
  <result pre="virus: From pathogenesis to disease controlFEMS Microbiol. Lett.2016363fnw20210.1093/femsle/fnw20227549304 16.SutharM.S.DiamondM.S.GaleM.Jr.West Nile" exact="virus infection" post="and immunityNat. Rev. Microbiol.20131111512810.1038/nrmicro295023321534 17.NandyA.DeyS.BasakS.C.Bielinska-WazD.WazP.Characterizing the Zika Virus Genomeâ€&quot;A"/>
  <result pre="From pathogenesis to disease controlFEMS Microbiol. Lett.2016363fnw20210.1093/femsle/fnw20227549304 16.SutharM.S.DiamondM.S.GaleM.Jr.West Nile virus" exact="infection" post="and immunityNat. Rev. Microbiol.20131111512810.1038/nrmicro295023321534 17.NandyA.DeyS.BasakS.C.Bielinska-WazD.WazP.Characterizing the Zika Virus Genomeâ€&quot;A"/>
  <result pre="March 2017Available online: http://apps.who.int/iris/bitstream/10665/254714/1/zikasitrep10Mar17-eng.pdf(accessed on 7 July 2019) 20.Centers for" exact="Disease" post="Control and Prevention (CDC)Available online: https://www.cdc.gov/zika/hc-providers/preparing-for-zika/clinicalevaluationdisease.html(accessed on 7 July"/>
  <result pre="and CausesAvailable online: https://www.mayoclinic.org/diseases-conditions/zika-virus/symptoms-causes/syc-20353639(accessed on 3 September 2019) 22.Cao-LormeauV.M.BlakeA.MonsS.LastereS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-BarrÃ©" exact="Syndrome" post="outbreak associated with Zika virus infection in French Polynesia:"/>
  <result pre="3 September 2019) 22.Cao-LormeauV.M.BlakeA.MonsS.LastereS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-BarrÃ© Syndrome outbreak associated with Zika" exact="virus infection" post="in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 23.ParraB.LizarazoJ.JorgeA.Jimenez-ArangoJ.A.Zea-VaraA.F.Gonzalez-ManriqueG.VargasJ.AngaritaJ.A.ZunigaG.Lopez-GonzalezR.et al.Guillainâ€&quot;BarrÃ© Syndrome"/>
  <result pre="September 2019) 22.Cao-LormeauV.M.BlakeA.MonsS.LastereS.RocheC.VanhomwegenJ.DubT.BaudouinL.TeissierA.LarreP.et al.Guillain-BarrÃ© Syndrome outbreak associated with Zika virus" exact="infection" post="in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 23.ParraB.LizarazoJ.JorgeA.Jimenez-ArangoJ.A.Zea-VaraA.F.Gonzalez-ManriqueG.VargasJ.AngaritaJ.A.ZunigaG.Lopez-GonzalezR.et al.Guillainâ€&quot;BarrÃ© Syndrome"/>
  <result pre="virus infection in French Polynesia: A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 23.ParraB.LizarazoJ.JorgeA.Jimenez-ArangoJ.A.Zea-VaraA.F.Gonzalez-ManriqueG.VargasJ.AngaritaJ.A.ZunigaG.Lopez-GonzalezR.et al.Guillainâ€&quot;BarrÃ©" exact="Syndrome" post="Associated with Zika Virus Infection in ColombiaN. Engl. J."/>
  <result pre="A case-control studyLancet20163871531153910.1016/S0140-6736(16)00562-626948433 23.ParraB.LizarazoJ.JorgeA.Jimenez-ArangoJ.A.Zea-VaraA.F.Gonzalez-ManriqueG.VargasJ.AngaritaJ.A.ZunigaG.Lopez-GonzalezR.et al.Guillainâ€&quot;BarrÃ© Syndrome Associated with Zika Virus" exact="Infection" post="in ColombiaN. Engl. J. Med.20163751513152310.1056/NEJMoa160556427705091 24.Zika Virus transmission Methods,"/>
  <result pre="EuropeAvailable online: http://news.bbc.co.uk/2/hi/health/4381924.stm(accessed on 7 July 2019) 26.PringleH.How Europeans Brought" exact="Sickness" post="to the New WorldAvailable online: https://www.sciencemag.org/news/2015/06/how-europeans-brought-sickness-new-world(accessed on 7 July"/>
  <result pre="Virus Surveillance, Vaccinology, and Anti-Zika Drug Discovery: Computer-Assisted Strategies to" exact="Combat" post="the MenaceBasakS.C.BhattacharjeeA.K.NandyA.NovaNew York, NY, USA2019978-1-53614-970-8 29.HethcoteH.The Mathematics of Infectious"/>
  <result pre="to Combat the MenaceBasakS.C.BhattacharjeeA.K.NandyA.NovaNew York, NY, USA2019978-1-53614-970-8 29.HethcoteH.The Mathematics of" exact="Infectious" post="DiseasesSIAM Rev.20004259965310.1137/S0036144500371907 30.SuparitP.WiratsudakulA.ModchangC.A mathematical model for Zika virus transmission"/>
  <result pre="Model.2018151110.1186/s12976-018-0083-z30064447 31.NishiuraH.MizumotoK.Villamil-GomezW.E.Rodriguez-MoralesA.J.Preliminary estimation of the basic reproduction number of Zika" exact="virus infection" post="during Colombia epidemic, 2015â€&quot;2016Trav. Med. Infect. Dis.20161427427610.1016/j.tmaid.2016.03.01627060613 32.MlakarJ.KorvaM.TulN.PopovicM.Poljsak-PriteljM.MrazJ.KolencJ.RusK.R.VipotnikT.V.VodusekV.F.et al.Zika"/>
  <result pre="31.NishiuraH.MizumotoK.Villamil-GomezW.E.Rodriguez-MoralesA.J.Preliminary estimation of the basic reproduction number of Zika virus" exact="infection" post="during Colombia epidemic, 2015â€&quot;2016Trav. Med. Infect. Dis.20161427427610.1016/j.tmaid.2016.03.01627060613 32.MlakarJ.KorvaM.TulN.PopovicM.Poljsak-PriteljM.MrazJ.KolencJ.RusK.R.VipotnikT.V.VodusekV.F.et al.Zika"/>
  <result pre="Virus Surveillance, Vaccinology, and Anti-Zika Drug Discovery: Computer-Assisted Strategies to" exact="Combat" post="the MenaceBasakS.C.BhattacharjeeA.K.NandyA.NovaNew York, NY, USA2019129152 36.WiratsudakulA.SuparitP.ModchangC.Dynamics of Zika virus"/>
  <result pre="data sparsity to identify potential sources of Zika virus spillover" exact="infection" post="among primatesEpidemics201927596510.1016/j.epidem.2019.01.00530902616 38.SahooM.JenaL.DafS.KumarS.Virtual Screening for Potential Inhibitors of NS3"/>
  <result pre="infection among primatesEpidemics201927596510.1016/j.epidem.2019.01.00530902616 38.SahooM.JenaL.DafS.KumarS.Virtual Screening for Potential Inhibitors of NS3" exact="Protein" post="of Zika VirusGenomics Inform.20161410411110.5808/GI.2016.14.3.10427729840 39.SinghA.JanaN.K.Discovery of potential Zika virus"/>
  <result pre="Struct. Dyn.2018361118113310.1080/07391102.2017.131317528351337 41.BalasubramanianA.TeramotoT.KulkarniA.A.BhattacharjeeA.K.PadmanabhanR.Antiviral activities of selected antimalarials against dengue virus" exact="type 2" post="and Zika virusAntivir. Res.201713714115010.1016/j.antiviral.2016.11.01527889529 42.SinigagliaA.RiccettiS.TrevisanM.BarzonL.In silico approaches to Zika"/>
  <result pre="of YFV 17D-based chimeric vaccines against dengue, West Nile and" exact="Japanese encephalitis" post="virusesVaccine20102863264910.1016/j.vaccine.2009.09.09819808029 48.WHO Vaccine Pipeline TrackerAvailable online: https://docs.google.com/spreadsheets/d/19otvINcayJURCMg76xWO4KvuyedYbMZDcXqbyJGdcZM/pubhtml#(accessed on 15"/>
  <result pre="YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese" exact="encephalitis" post="virusesVaccine20102863264910.1016/j.vaccine.2009.09.09819808029 48.WHO Vaccine Pipeline TrackerAvailable online: https://docs.google.com/spreadsheets/d/19otvINcayJURCMg76xWO4KvuyedYbMZDcXqbyJGdcZM/pubhtml#(accessed on 15"/>
  <result pre="with molecular dynamics simulations to predict antigenic epitopes of Zika" exact="viral" post="proteinsSci. Rep.201663731310.1038/srep4463327934901 55.DeyS.DasS.NandyA.Characterization of Zika and Other Human Infecting"/>
  <result pre="Antiviral Drug/Vaccine DesignPLoS ONE20127e4074910.1371/journal.pone.004074922844409 61.DeyS.DeA.NandyA.Rational Design of Peptide Vaccines Against" exact="Multiple" post="Types of Human PapillomavirusCancer Inform.20161511610.4137/CIN.S39071 62.DeyS.NandyA.BasakS.C.NandyP.DasS.A Bioinformatics approach to"/>
  <result pre="Clin. Investig.20021101765176810.1172/JCI1740512488425 64.LiuF.FeuerR.HassettD.E.WhittonJ.L.Peptide vaccination of mice immune to LCMV or" exact="vaccinia" post="virus causes serious CD8+ T cell mediated, TNF-dependent immunopathologyJ."/>
  <result pre="SequencesJ. Chem. Inf. Comput. Sci.19993924324710.1021/ci980077v10192941 78.RandiÄ‡M.VrackoM.NovicM.PlavsicD.Spectrum-Like Graphical Representation of RNA" exact="Secondary" post="StructureInt. J. Quantum Chem.20091092982299510.1002/qua.22175 79.JohnsonM.BasakS.C.MaggioraG.A characterization of molecular similarity"/>
  <result pre="methods for property predictionMath. Comput. Model.19881163063410.1016/0895-7177(88)90569-9 80.Roy ChoudhuryA.ZhukovN.VrackoM.Mathematical Characterization of" exact="Protein" post="Transmembrane RegionsSci. World. J.2013201360783010.1155/2013/60783023690747 81.VrackoM.BasakS.C.NandyA.SenD.Clustering of Zika viruses originating"/>
  <result pre="offer a multitude of options for inhibitor designAntivir. Res.201613071810.1016/j.antiviral.2016.02.01426944216 92.BermanH.M.WestbrookJ.FengZ.GillilandG.BhatT.N.WeissigH.ShindyalovI.N.BourneP.E.The" exact="Protein" post="Data BankNucleic Acids Res.20002823524210.1093/nar/28.1.23510592235 93.BarrowsN.J.CamposR.K.PowellS.T.PrasanthK.R.Schott-LernerG.Soto-AcostaR.Galarza-MuÃ±ozG.McGrathE.L.Urrabaz-GarzaR.GaoJ.et al.A screen of FDA-approved"/>
  <result pre="infectionCell Host Microbe20162025927010.1016/j.chom.2016.07.00427476412 94.XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.et al.Identification of small-molecule inhibitors of Zika" exact="virus infection" post="and induced neural cell death via a drug repurposing"/>
  <result pre="Host Microbe20162025927010.1016/j.chom.2016.07.00427476412 94.XuM.LeeE.M.WenZ.ChengY.HuangW.K.QianX.TcwJ.KouznetsovaJ.OgdenS.C.HammackC.et al.Identification of small-molecule inhibitors of Zika virus" exact="infection" post="and induced neural cell death via a drug repurposing"/>
  <result pre="Med.2018168410.1186/s12916-018-1067-x29871628 98.DelvecchioR.HigaL.M.PezzutoP.ValadaoA.L.GarcezP.P.MonteiroF.L.LoiolaE.C.DiasA.A.SilvaF.J.M.AliotaM.T.et al.Chloroquine, an Endocytosis Blocking Agent, Inhibits Zika Virus" exact="Infection" post="in Different Cell ModelsViruses2016832210.3390/v812032227916837 99.DevillersJ.Repurposing drugs for use against"/>
  <result pre="Zika virus replicationAntivir. Res.201713713113310.1016/j.antiviral.2016.11.02027902932 102.MunjalA.KhandiaR.DhamaK.SachanS.KarthikK.TiwariR.MalikY.S.KumarD.SinghR.K.IqbalH.M.N.et al.Advances in Developing Therapies to" exact="Combat" post="Zika Virus: Current Knowledge and Future PerspectivesFront. Microbiol.20178146910.3389/fmicb.2017.0146928824594 103.EkinsS.MietchenD.CoffeeM.StrattonT.P.FreundlichJ.S.Freitas-JuniorL.MuratovE.Siqueira-NetoJ.WilliamsA.J.AndradeC.Open"/>
  <result pre="for drug discoveryAntivir. Res.2015118394510.1016/j.antiviral.2015.03.00725796970 118.XieX.WangQ.Y.XuH.Y.QingM.KramerL.YuanZ.ShiP.Y.Inhibition of dengue virus by targeting" exact="viral" post="NS4B proteinJ. Virol.201185111831119510.1128/JVI.05468-1121865382 119.van CleefK.W.OverheulG.J.ThomassenM.C.KapteinS.J.DavidsonmA.D.JacobsM.NeytsJ.van KuppeveldF.J.van RijR.P.Identification of a"/>
  <result pre="RijR.P.Identification of a new dengue virus inhibitor that targets the" exact="viral" post="NS4B protein and restricts genomic RNA replicationAntivir. Res.20139916517110.1016/j.antiviral.2013.05.01123735301 120.StephenP.BazM.BolvinG.LinS.X.Structural"/>
  <result pre="protein as a target for drug discoveryAntivir. Res.2015119576710.1016/j.antiviral.2015.04.01025912817 123.BekermanE.EinavS.Combating emerging" exact="viral" post="threatsScience201534828228310.1126/science.aaa377825883340 124.Seley-RadtkeK.L.YatesM.K.The evolution of nucleoside analogue antivirals: A review"/>
  <result pre="nucleoside scaffoldAntivir. Res.2018154668610.1016/j.antiviral.2018.04.00429649496 125.Lucas-HouraniM.DauzonneD.JordaP.CousinG.LupanA.HelynckO.CaignardG.JanvierG.AndrÃ©-LerouxG.KhiarS.et al.Inhibition of pyrimidine biosynthesis pathway suppresses" exact="viral" post="growth through innate immunityPLoS Pathog.20139e100367810.1371/journal.ppat.100367824098125 126.CranceJ.M.ScaramozzinoN.JouanA.GarinD.Interferon, ribavirin, 6-azauridine and"/>
  <result pre="Antiviral compounds active against pathogenic flavivirusesAntivir. Res.200358737910.1016/S0166-3542(02)00185-712719009 127.XieY.OgahC.A.JiangX.LiJ.ShenJ.Nucleoside inhibitors of" exact="hepatitis C" post="virus NS5B polymerase: A systematic reviewCurr. Drug Targets2016171560157610.2174/138945011766615120912375126648061 128.JulanderJ.G.SiddharthanV.EvansJ.TaylorR.TolbertK.ApuliC.StewartJ.CollinsP.GebreM.NeilsonS.et"/>
  <result pre="silico screeningAntivir. Res.2018151788610.1016/j.antiviral.2017.12.01629274845 131.YangS.XuM.LeeE.M.ShiryaevS.A.HeS.SunW.ChengY.-S.HuX.TharappelA.M.LuB.et al.Emetine inhibits Zika and Ebola virus" exact="infections" post="through two molecular mechanisms: Inhibiting viral replication and decreasing"/>
  <result pre="Zika and Ebola virus infections through two molecular mechanisms: Inhibiting" exact="viral" post="replication and decreasing viral entryCell Discov.2018410.1038/s41421-018-0034-129872540 132.PereraR.RileyC.IsaacG.Hopf-JannaschA.S.MooreR.J.WeitzK.W.Pasa-TolicL.MetzT.O.AdamecJ.KuhnR.J.Dengue virus infection"/>
  <result pre="infections through two molecular mechanisms: Inhibiting viral replication and decreasing" exact="viral" post="entryCell Discov.2018410.1038/s41421-018-0034-129872540 132.PereraR.RileyC.IsaacG.Hopf-JannaschA.S.MooreR.J.WeitzK.W.Pasa-TolicL.MetzT.O.AdamecJ.KuhnR.J.Dengue virus infection perturbs lipid homeostasis in"/>
  <result pre="mechanisms: Inhibiting viral replication and decreasing viral entryCell Discov.2018410.1038/s41421-018-0034-129872540 132.PereraR.RileyC.IsaacG.Hopf-JannaschA.S.MooreR.J.WeitzK.W.Pasa-TolicL.MetzT.O.AdamecJ.KuhnR.J.Dengue" exact="virus infection" post="perturbs lipid homeostasis in infected mosquito cellsPLoS Pathog.2012810.1371/journal.ppat.100258422457619 133.StevensonB.ChoyH.A.PinneM.RotondiM.L.MillerM.C.DemollE.KraiczyP.CooleyA.E.CreamerT.P.SuchardM.A.et"/>
  <result pre="Inhibiting viral replication and decreasing viral entryCell Discov.2018410.1038/s41421-018-0034-129872540 132.PereraR.RileyC.IsaacG.Hopf-JannaschA.S.MooreR.J.WeitzK.W.Pasa-TolicL.MetzT.O.AdamecJ.KuhnR.J.Dengue virus" exact="infection" post="perturbs lipid homeostasis in infected mosquito cellsPLoS Pathog.2012810.1371/journal.ppat.100258422457619 133.StevensonB.ChoyH.A.PinneM.RotondiM.L.MillerM.C.DemollE.KraiczyP.CooleyA.E.CreamerT.P.SuchardM.A.et"/>
  <result pre="responsesCell Rep.20171832433310.1016/j.celrep.2016.12.04528076778 138.WangZ.Y.WangZ.ZhenZ.D.FengK.H.GuoJ.GaoN.FanD.Y.HanD.S.WangP.G.AnJ.Axl is not an indispensable factor for zika" exact="virus infection" post="in miceJ. Gen. Virol.2017982061206810.1099/jgv.0.00088628786784 139.BlazquezA.B.Escribano-RomeroE.Merino-RamosT.SaizJ.-C.Martin-AcebesM.A.Stress responses in flavivirus-infected cells:"/>
  <result pre="Rep.20171832433310.1016/j.celrep.2016.12.04528076778 138.WangZ.Y.WangZ.ZhenZ.D.FengK.H.GuoJ.GaoN.FanD.Y.HanD.S.WangP.G.AnJ.Axl is not an indispensable factor for zika virus" exact="infection" post="in miceJ. Gen. Virol.2017982061206810.1099/jgv.0.00088628786784 139.BlazquezA.B.Escribano-RomeroE.Merino-RamosT.SaizJ.-C.Martin-AcebesM.A.Stress responses in flavivirus-infected cells:"/>
  <result pre="and autophagyFront. Microbiol.201451710.3389/fmicb.2014.0026624478763 140.KuivanenS.BespalovM.M.NandaniaJ.IanevskiA.VelagapudiV.De BrabanderJ.K.KainovD.E.VapalahtiO.Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika" exact="virus infection" post="in vitro and differentially affect cellular signaling, transcription and"/>
  <result pre="autophagyFront. Microbiol.201451710.3389/fmicb.2014.0026624478763 140.KuivanenS.BespalovM.M.NandaniaJ.IanevskiA.VelagapudiV.De BrabanderJ.K.KainovD.E.VapalahtiO.Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus" exact="infection" post="in vitro and differentially affect cellular signaling, transcription and"/>
  <result pre="RNA during Zika virus 980 infectionVirus Res.2017254415310.1016/j.virusres.2017.08.01528864425 149.HermannT.Small molecules targeting" exact="viral" post="RNAWiley Interdiscip. Rev. RNA2016772674310.1002/wrna.137327307213 150.ConnellyC.M.MoonM.H.SchneeklothJ.S.Jr.The emerging role of RNA"/>
  <result pre="153.OliveiraA.F.TeixeiraR.R.OliveiraA.S.SouzaA.P.SilvaM.L.PaulaS.O.Potential antivirals: Natural products targeting replication enzymes of dengue and" exact="chikungunya" post="virusesMolecules20172250510.3390/molecules22030505 154.ValadaoA.L.AguiarR.S.de ArrudaL.B.Interplay between inflammation and cellular stress triggered"/>
  <result pre="virusesFront. Microbiol.20167123310.3389/fmicb.2016.0123327610098 155.LiC.ZhuX.JiX.QuanquinN.DengY.-Q.TianM.AliyariR.ZuoX.YuanL.AfridiS.K.et al.Chloroquine, a FDA-approved drug, prevents Zika Virus" exact="infection" post="and its associated congenital microcephaly in miceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372 156.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing"/>
  <result pre="a FDA-approved drug, prevents Zika Virus infection and its associated" exact="congenital" post="microcephaly in miceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372 156.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing of the anti-malaria drug"/>
  <result pre="FDA-approved drug, prevents Zika Virus infection and its associated congenital" exact="microcephaly" post="in miceEBioMedicine20172418919410.1016/j.ebiom.2017.09.03429033372 156.ShiryaevS.A.MesciP.PintoA.FernandesI.SheetsN.ShrestaS.FarhyC.HuangC.-T.StronginA.Y.MuotriA.R.et al.Repurposing of the anti-malaria drug chloroquine"/>
  <result pre="screening in hPSC-neural progenitors identifies drug candidates that inhibit Zika" exact="virus infection" post="in fetal-like organoids and adult brainCell Stem Cell20172127428310.1016/j.stem.2017.06.01728736217 159.CaoB.ParnellL.A.DiamondM.S.MysorekarI.U.Inhibition"/>
  <result pre="in hPSC-neural progenitors identifies drug candidates that inhibit Zika virus" exact="infection" post="in fetal-like organoids and adult brainCell Stem Cell20172127428310.1016/j.stem.2017.06.01728736217 159.CaoB.ParnellL.A.DiamondM.S.MysorekarI.U.Inhibition"/>
  <result pre="candidates that inhibit Zika virus infection in fetal-like organoids and" exact="adult" post="brainCell Stem Cell20172127428310.1016/j.stem.2017.06.01728736217 159.CaoB.ParnellL.A.DiamondM.S.MysorekarI.U.Inhibition of autophagy limits vertical transmission"/>
  <result pre="potential for host-targeted iminosugars UV-4 and UV-5 activity against filovirus" exact="infections" post="in vitro and in vivoAntivir. Res.2017138223110.1016/j.antiviral.2016.11.01927908828 161.Adolf-BryfogleJ.KalyuzhniyO.KubitzM.WeitznerB.D.HuX.AdachiY.SchiefW.R.DunbrackR.L.Jr.RosettaAntibodyDesign (RAbD): A"/>
  <result pre="Modeling AnalysisSci. Rep.201662807010.1038/srep2807027312324 169.SinclairR.M.RavanttiJ.J.BamfordD.H.Nucleic and Amino Acid Sequences Support Structure-Based" exact="Viral" post="ClassificationJ. Virol.201791e02275-1610.1128/JVI.02275-1628122979 170.van HemertF.JebbinkM.van der ArkA.ScholerF.BerkhoutB.Euclidean Distance Analysis Enables"/>
  <result pre="HemertF.JebbinkM.van der ArkA.ScholerF.BerkhoutB.Euclidean Distance Analysis Enables Nucleotide Skew Analysis in" exact="Viral" post="GenomesComp. Math. Meth. Med.20182018649064710.1155/2018/649064730510593 171.RenJ.BaiX.LuY.Y.TangK.WangY.ReinertG.SunF.Alignment-Free Sequence Analysis and ApplicationsAnnu."/>
  <result pre="with its accession number, country, and year of collection. The" exact="horizontal" post="axis shows relative amount of character change between different"/>
  <result pre="taken from ZIKV isolate ZIKV/H. sapiens/Brazil/PE243/2015 (GenBank Locus ID KX197192)," exact="complete" post="genome. E: envelope; NS: non-structural; nt: nucleotide; prM/M: pre-membrane/membrane;"/>
  <result pre="cleaved and mature virions formed with M. E 978â€&quot;2489 1512" exact="Viral" post="entry into host cell. NS1 2490â€&quot;3545 1056 Viral replication,"/>
  <result pre="978â€&quot;2489 1512 Viral entry into host cell. NS1 2490â€&quot;3545 1056" exact="Viral" post="replication, immune evasion, genome synthesis. NS2A 3546â€&quot;4223 678 Transmembrane"/>
  <result pre="NS3; proteolytic processing. NS3 4614â€&quot;6464 1851 Protease/helicase. NS4A 6465â€&quot;6914 381" exact="Viral" post="RNA replication and amplification. 2K 6846â€&quot;6914 69 Peptide generated"/>
  <result pre="terminus of the NS4B signal sequence. NS4B 6915â€&quot;7667 753 Facilitates" exact="viral" post="replication complexes; counteracts innate immune responses. NS5 7668â€&quot;10376 2709"/>
  <result pre="7668â€&quot;10376 2709 Methyltransferase; RNA-dependent RNA polymerase. 3â€²-UTR 10380â€&quot;10807 427 Facilitates" exact="viral" post="replication and translation. pharmaceuticals-12-00157-t002_Table 2Table 2 The pre-epidemics period"/>
  <result pre="in children. 1952 Uganda, Tanganyika First human cases of ZIKV" exact="infection" post="detected. India ZIKV antibodies found in human blood. 1953"/>
  <result pre="North Borneo, Philippines ZIKV antibodies found in residents. Nigeria ZIKV" exact="infection" post="detected in three persons. 1954 Egypt, Vietnam ZIKV antibodies"/>
  <result pre="forest. 1960 Angola ZIKV antibodies found in indigenous residents. 1961â€&quot;1962" exact="Central" post="African Republic ZIKV antibodies found in human blood. 1961â€&quot;1964"/>
  <result pre="1960 Angola ZIKV antibodies found in indigenous residents. 1961â€&quot;1962 Central" exact="African" post="Republic ZIKV antibodies found in human blood. 1961â€&quot;1964 Ethiopia"/>
  <result pre="blood. 1962 Senegal ZIKV antibodies found in human blood. 1963â€&quot;1964" exact="Central" post="African Republic, Burkina-Faso ZIKV antibodies found in human blood."/>
  <result pre="1962 Senegal ZIKV antibodies found in human blood. 1963â€&quot;1964 Central" exact="African" post="Republic, Burkina-Faso ZIKV antibodies found in human blood. 1963â€&quot;1965"/>
  <result pre="1972,1975, 1988,1990 Senegal ZIKV antibodies found in human blood. 1979" exact="Central" post="African Republic ZIKV antibodies found in human blood. 1980"/>
  <result pre="1988,1990 Senegal ZIKV antibodies found in human blood. 1979 Central" exact="African" post="Republic ZIKV antibodies found in human blood. 1980 Nigeria"/>
  <result pre="traveler infected in Senegal returning to home country and passing" exact="infection" post="through sexual contact. 2010 Cameroon ZIKV antibodies found in"/>
  <result pre="ZIKV in these countries to travelers who then carried the" exact="infection" post="to their home countries. 2011â€&quot;2014 French Polynesia Second reported"/>
  <result pre="French Polynesia Second reported outbreak of ZIKV infections. Connection with" exact="microcephaly" post="and neurological disorders established later. 2013â€&quot;2014 Chile, Cook Islands,New"/>
  <result pre="laboratory tests in 12 states. Neurological disorders associated with prior" exact="viral" post="infections detected primarily in the Bahia region. 2015 October"/>
  <result pre="tests in 12 states. Neurological disorders associated with prior viral" exact="infections" post="detected primarily in the Bahia region. 2015 October South"/>
  <result pre="infections.Brazil reported unusual increase in the number of cases of" exact="neonatal" post="microcephaly. 2015 November Central and South America Brazil reported"/>
  <result pre="in the number of cases of neonatal microcephaly. 2015 November" exact="Central" post="and South America Brazil reported 141 suspected cases of"/>
  <result pre="Central and South America Brazil reported 141 suspected cases of" exact="microcephaly" post="and declared a national public health emergency. Brazil reported"/>
  <result pre="Guatemala, and Paraguay confirmed cases of ZIKV infection. The Pan" exact="American" post="Health Organization and WHO issued an epidemiological alert. 2015"/>
  <result pre="an epidemiological alert. 2015 November Mexico Three cases of ZIKV" exact="infection" post="confirmed by PCR. 2015 November French Polynesia Retrospective analysis"/>
  <result pre="November French Polynesia Retrospective analysis reveals unusually large number of" exact="central nervous system" post="malformations in fetuses and infants in 2014â€&quot;2015. 2015 December"/>
  <result pre="Retrospective analysis reveals unusually large number of central nervous system" exact="malformations" post="in fetuses and infants in 2014â€&quot;2015. 2015 December Central"/>
  <result pre="system malformations in fetuses and infants in 2014â€&quot;2015. 2015 December" exact="Central" post="and South America Honduras, French Guiana, and Martinique reported"/>
  <result pre="infections. 2015 December Puerto Rico First confirmed case of Zika" exact="infection" post="reported. 2016 Maldives Finnish national working in Maldivestested positive"/>
  <result pre="Rico First confirmed case of Zika infection reported. 2016 Maldives" exact="Finnish" post="national working in Maldivestested positive for Zika after return"/>
  <result pre="January Americas Guyana reported the first PCR-confirmed case of locally" exact="acquired" post="Zika infection.Ecuador, Bolivia, Barbados, Haiti, Dominican Republic, Nicaragua, Curacao"/>
  <result pre="Croix reported. 2016 February Americas First confirmed case of ZIKV" exact="infection" post="in Chile reported.First case of sexually transmitted Zika infection"/>
  <result pre="ZIKV infection in Chile reported.First case of sexually transmitted Zika" exact="infection" post="in Texas, USA reported. 2016 Various countries Angola, Antigua,"/>
  <result pre="countries report first cases of ZIKV infections. 2016 Singapore ZIKV" exact="infection" post="reported. 2016/2017 India Three cases of ZIKV infection reported"/>
  <result pre="Singapore ZIKV infection reported. 2016/2017 India Three cases of ZIKV" exact="infection" post="reported in Ahmedabad. 2017 Singapore Several cases of locally"/>
  <result pre="d Locus ID Year Country Host Africa 83.1238 KF268949 1980" exact="Central" post="African Republic Aedes opok 226.8671 KF383115 1968 Central African"/>
  <result pre="Locus ID Year Country Host Africa 83.1238 KF268949 1980 Central" exact="African" post="Republic Aedes opok 226.8671 KF383115 1968 Central African Republic"/>
  <result pre="KF268949 1980 Central African Republic Aedes opok 226.8671 KF383115 1968" exact="Central" post="African Republic Aedes africanus 187.0571 KF383116 1968 Senegal Aedes"/>
  <result pre="1980 Central African Republic Aedes opok 226.8671 KF383115 1968 Central" exact="African" post="Republic Aedes africanus 187.0571 KF383116 1968 Senegal Aedes luteocephalus"/>
  <result pre="and Ivermectin Hybrid drugs against co-infections of ZIKV, dengue and" exact="chikungunya" post="[100] 20-Cmethylated nucleosides Inhibitors of RNA-dependent RNA polymerase (RdRp)"/>
  <result pre="RNA polymerase (RdRp) [101] NS3 inhibitors Covalent inhibitors of a" exact="viral" post="protein and anti-Toll-like receptor molecules [102] FDA-approved drugs In"/>
  <result pre="led to twenty compounds that were found to reduce ZIKV" exact="infection" post="[93] NIH clinical library of compounds By screening 725"/>
  <result pre="(Pubchem CID: 6337614) and Kitasamycin (Pubchem CID: 44634697). [103] A" exact="limited" post="proprietary library of small organic compounds Anti-ZIKV activity through"/>
  <result pre="replication of wild-type ZIKV both in cell lines and in" exact="primary" post="human fetal endothelial cells. Interestingly, the NSAIDs exerted this"/>
  <result pre="An adenosine nucleoside analog, functions as a selective inhibitor of" exact="viral" post="RNA-dependent RNA polymerase (RdRp). It was found that BCX4430"/>
  <result pre="selective index (SI) values. In a mouse model of ZIKV" exact="infection" post="(300 mg/kg/d), treatment with BCX4430 showed promising results. The"/>
 </snippets>
</snippetsTree>
